CNS Pharmaceuticals (CNSP) Cash from Operations (2018 - 2025)
CNS Pharmaceuticals' (CNSP) quarterly Cash from Operations came in at 3051770.0 in Q4 2025, up 44.22% YoY from 2116085.35 in Q4 2024, and down 40.36% on a QoQ basis from 2174170.0 in Q3 2025.
CNS Pharmaceuticals (CNSP) Cash from Operations (2018 - 2025) Analysis & Trends
CNS Pharmaceuticals (CNSP) has 8 years of Cash from Operations data on file, last reported at 3051770.0 in Q4 2025.
- Quarterly Cash from Operations rose 44.22% year-over-year to 3051770.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 13811107.0 (up 19.3% YoY) and the FY2025 annual result came in at 13811107.0, up 19.3% from the prior year.
- Cash from Operations slipped to 3051770.0 in Q4 2025, from 2174170.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 1650393.0 in Q2 2024 to a low of 6799990.0 in Q3 2024.
- A 5-year average of 3458028.05 and a median of 3239354.5 in 2021 frame the typical range for Cash from Operations.
- The widest YoY moves for Cash from Operations: up 68.03% in 2025, down 223.76% in 2025.
- Tracing CNSP's Cash from Operations over 5 years: stood at 3236802.0 in 2021, then advanced by 28.78% to 2305323.0 in 2022, then dropped by 10.02% to 2536353.0 in 2023, then slumped by 115.7% to 5470859.0 in 2024, then surged by 44.22% to 3051770.0 in 2025.
- The last three Cash from Operations figures came in at 3051770.0 (Q4 2025), 2174170.0 (Q3 2025), and 5343260.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 326.72 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -88.83 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 728.46 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 360.27 Mn |
| 10 | CNS Pharmaceuticals | 2.66 Mn | -4.54 Mn | - | -3.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.05 Mn |
| Dec 31, 2025 | -3.05 Mn |
| Sep 30, 2025 | -2.17 Mn |
| Sep 30, 2025 | -2.17 Mn |
| Jun 30, 2025 | -5.34 Mn |
| Jun 30, 2025 | -5.34 Mn |
| Mar 31, 2025 | -3.24 Mn |
| Mar 31, 2025 | -3.24 Mn |
| Dec 31, 2024 | -5.47 Mn |
| Dec 31, 2024 | -5.47 Mn |
| Sep 30, 2024 | -6.80 Mn |
| Sep 30, 2024 | -6.80 Mn |
| Jun 30, 2024 | -1.65 Mn |
| Jun 30, 2024 | -1.65 Mn |
| Mar 31, 2024 | -3.19 Mn |
| Mar 31, 2024 | -3.19 Mn |
| Dec 31, 2023 | -2.54 Mn |
| Dec 31, 2023 | -2.54 Mn |
| Sep 30, 2023 | -3.38 Mn |
| Sep 30, 2023 | -3.38 Mn |